DGEN (DGEN) Stock Price & Analysis
DGEN (DGEN) rose 0.00% to USD 0 as of June 10, 2026 at 12:28 UTC, according to Nexqual real-time market data.
DGEN last closed at USD 0; the session ranged USD 0–0 on volume of 442,968 shares. Market capitalization is $2.75M, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 12:28 UTC.
Key Statistics (as of June 10, 2026 at 12:28 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 442,968 shares |
| Market Cap | $2.75M |
| Exchange | PNK |
Technical Analysis (DGEN)
Nexqual's technical model rates DGEN "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 12:28 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (DGEN)
Wall Street analysts rate DGEN "None", per Nexqual as of June 10, 2026 at 12:28 UTC.
| Consensus Rating | None |
|---|
Earnings (DGEN)
Source: Nexqual, June 10, 2026 at 12:28 UTC.
Financials & Fundamentals (DGEN)
| Total Revenue | $770,000 |
|---|---|
| Gross Margin | +99.48% |
| Operating Margin | +29.28% |
| Profit Margin | -5.97% |
| ROE | -2.72% |
| Debt / Equity | 1.46 |
| Current Ratio | 1.45 |
| Total Cash | $23,000 |
| Total Debt | $25,000 |
| Free Cash Flow | $66,250 |
Source: Nexqual, June 10, 2026 at 12:28 UTC.
Financial Health Score (DGEN)
Nexqual rates DGEN's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 12:28 UTC.
| Growth | Strong — Revenue +376% YoY (annual) |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $23K cash, no debt |
| Cash Flow | Mixed — FCF $66K, slim 0.7% margin |
| Efficiency | Critical — ROE -3%, ROA -1.6% |
Ownership (DGEN)
| Shares Outstanding | 0 |
|---|
Source: Nexqual, June 10, 2026 at 12:28 UTC.
Leadership (DGEN)
DGEN is led by Robert J. Driscoll (age 59), CEO, President, Secretary & Director, per Nexqual as of June 10, 2026 at 12:28 UTC.
| CEO, President, Secretary & Director | Robert J. Driscoll (age 59) |
|---|---|
| Chief Financial Officer | Daniel Ratto (age 67) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| LEON | LEONE ASSET MANAGEMENT INC | USD 0.02 | ▼ 5.56% |
| GMNI | Gemini Group Global Corp. | USD 0 | ▲ 8.33% |
| FLRE | Flameret Inc | USD 0 | ▲ 0% |
| HMGN | HEMAGEN DIAGNOSTICS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:28 UTC. This page is informational and not investment advice.